- Home
- SLND vs TELO Comparison
SLND vs TELO Comparison
Compare SLND & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLND
- TELO
- Stock Information
- Founded
- SLND 1900
- TELO 2021
- Country
- SLND United States
- TELO United States
- Employees
- SLND N/A
- TELO N/A
- Industry
- SLND Military/Government/Technical
- TELO
- Sector
- SLND Industrials
- TELO
- Exchange
- SLND Nasdaq
- TELO NYSE
- Market Cap
- SLND 175.8M
- TELO 129.5M
- IPO Year
- SLND N/A
- TELO 2024
- Fundamental
- Price
- SLND $3.20
- TELO $4.54
- Analyst Decision
- SLND Buy
- TELO
- Analyst Count
- SLND 2
- TELO 0
- Target Price
- SLND $5.50
- TELO N/A
- AVG Volume (30 Days)
- SLND 38.4K
- TELO 132.9K
- Earning Date
- SLND 03-04-2025
- TELO 02-04-2025
- Dividend Yield
- SLND N/A
- TELO N/A
- EPS Growth
- SLND N/A
- TELO N/A
- EPS
- SLND N/A
- TELO N/A
- Revenue
- SLND $980,179,000.00
- TELO N/A
- Revenue This Year
- SLND N/A
- TELO N/A
- Revenue Next Year
- SLND $6.18
- TELO N/A
- P/E Ratio
- SLND N/A
- TELO N/A
- Revenue Growth
- SLND N/A
- TELO N/A
- 52 Week Low
- SLND $1.85
- TELO $3.11
- 52 Week High
- SLND $6.16
- TELO $9.39
- Technical
- Relative Strength Index (RSI)
- SLND 48.19
- TELO 56.17
- Support Level
- SLND $3.13
- TELO $4.03
- Resistance Level
- SLND $3.60
- TELO $4.49
- Average True Range (ATR)
- SLND 0.21
- TELO 0.33
- MACD
- SLND 0.00
- TELO 0.06
- Stochastic Oscillator
- SLND 30.00
- TELO 92.50
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.